To amend title 18, United States Code, to prohibit theft of medical products, and for other purposes.

SECTION 1. SHORT TITLE.
    This Act may be cited as the ``Strengthening and Focusing 
Enforcement to Deter Organized Stealing and Enhance Safety Act of 
2012'' or the ``SAFE DOSES Act''.
SEC. 2. THEFT OF MEDICAL PRODUCTS.
    (a) Prohibited Conduct and Penalties.--Chapter 31 of title 18, 
United States Code, is amended by adding at the end the following:
``Sec. 670. Theft of medical products
    ``(a) Prohibited Conduct.--Whoever, in, or using any means or 
facility of, interstate or foreign commerce--
        ``(1) embezzles, steals, or by fraud or deception obtains, or 
    knowingly and unlawfully takes, carries away, or conceals a pre-
    retail medical product;
        ``(2) knowingly and falsely makes, alters, forges, or 
    counterfeits the labeling or documentation (including documentation 
    relating to origination or shipping) of a pre-retail medical 
    product;
        ``(3) knowingly possesses, transports, or traffics in a pre-
    retail medical product that was involved in a violation of 
    paragraph (1) or (2);
        ``(4) with intent to defraud, buys, or otherwise obtains, a 
    pre-retail medical product that has expired or been stolen;
        ``(5) with intent to defraud, sells, or distributes, a pre-
    retail medical product that is expired or stolen; or
        ``(6) attempts or conspires to violate any of paragraphs (1) 
    through (5);
shall be punished as provided in subsection (c) and subject to the 
other sanctions provided in this section.
    ``(b) Aggravated Offenses.--An offense under this section is an 
aggravated offense if--
        ``(1) the defendant is employed by, or is an agent of, an 
    organization in the supply chain for the pre-retail medical 
    product; or
        ``(2) the violation--
            ``(A) involves the use of violence, force, or a threat of 
        violence or force;
            ``(B) involves the use of a deadly weapon;
            ``(C) results in serious bodily injury or death, including 
        serious bodily injury or death resulting from the use of the 
        medical product involved; or
            ``(D) is subsequent to a prior conviction for an offense 
        under this section.
    ``(c) Criminal Penalties.--Whoever violates subsection (a)--
        ``(1) if the offense is an aggravated offense under subsection 
    (b)(2)(C), shall be fined under this title or imprisoned not more 
    than 30 years, or both;
        ``(2) if the value of the medical products involved in the 
    offense is $5,000 or greater, shall be fined under this title, 
    imprisoned for not more than 15 years, or both, but if the offense 
    is an aggravated offense other than one under subsection (b)(2)(C), 
    the maximum term of imprisonment is 20 years; and
        ``(3) in any other case, shall be fined under this title, 
    imprisoned for not more than 3 years, or both, but if the offense 
    is an aggravated offense other than one under subsection (b)(2)(C), 
    the maximum term of imprisonment is 5 years.
    ``(d) Civil Penalties.--Whoever violates subsection (a) is subject 
to a civil penalty in an amount not more than the greater of--
        ``(1) three times the economic loss attributable to the 
    violation; or
        ``(2) $1,000,000.
    ``(e) Definitions.--In this section--
        ``(1) the term `pre-retail medical product' means a medical 
    product that has not yet been made available for retail purchase by 
    a consumer;
        ``(2) the term `medical product' means a drug, biological 
    product, device, medical food, or infant formula;
        ``(3) the terms `device', `drug', `infant formula', and 
    `labeling' have, respectively, the meanings given those terms in 
    section 201 of the Federal Food, Drug, and Cosmetic Act;
        ``(4) the term `biological product' has the meaning given the 
    term in section 351 of the Public Health Service Act;
        ``(5) the term `medical food' has the meaning given the term in 
    section 5(b) of the Orphan Drug Act; and
        ``(6) the term `supply chain' includes manufacturer, 
    wholesaler, repacker, own-labeled distributor, private-label 
    distributor, jobber, broker, drug trader, transportation company, 
    hospital, pharmacy, or security company.''.
    (b) Clerical Amendment.--The table of sections at the beginning of 
chapter 31 of title 18, United States Code, is amended by adding after 
the item relating to section 669 the following:

``670. Theft of medical products.''.
SEC. 3. CIVIL FORFEITURE.
    Section 981(a)(1)(C) of title 18, United States Code, is amended by 
inserting ``670,'' after ``657,''.
SEC. 4. PENALTIES FOR THEFT-RELATED OFFENSES.
    (a) Interstate or Foreign Shipments by Carrier.--Section 659 of 
title 18, United States Code, is amended by adding at the end of the 
fifth undesignated paragraph the following: ``If the offense involves a 
pre-retail medical product (as defined in section 670), it shall be 
punished under section 670 unless the penalties provided for under this 
section are greater.''.
    (b) Racketeering.--
        (1) Travel act violations.--Section 1952 of title 18, United 
    States Code, is amended by adding at the end the following:
    ``(d) If the offense under this section involves an act described 
in paragraph (1) or (3) of subsection (a) and also involves a pre-
retail medical product (as defined in section 670), the punishment for 
the offense shall be the same as the punishment for an offense under 
section 670 unless the punishment under subsection (a) is greater.''.
        (2) Money laundering.--Section 1957(b)(1) of title 18, United 
    States Code, is amended by adding at the end the following: ``If 
    the offense involves a pre-retail medical product (as defined in 
    section 670) the punishment for the offense shall be the same as 
    the punishment for an offense under section 670 unless the 
    punishment under this subsection is greater.''.
    (c) Breaking or Entering Carrier Facilities.--Section 2117 of title 
18, United States Code, is amended by adding at the end of the first 
undesignated paragraph the following: ``If the offense involves a pre-
retail medical product (as defined in section 670) the punishment for 
the offense shall be the same as the punishment for an offense under 
section 670 unless the punishment under this section is greater.''.
    (d) Stolen Property.--
        (1) Transportation of stolen goods and related offenses.--
    Section 2314 of title 18, United States Code, is amended by adding 
    at the end of the sixth undesignated paragraph the following: ``If 
    the offense involves a pre-retail medical product (as defined in 
    section 670) the punishment for the offense shall be the same as 
    the punishment for an offense under section 670 unless the 
    punishment under this section is greater.''.
        (2) Sale or receipt of stolen goods and related offenses.--
    Section 2315 of title 18, United States Code, is amended by adding 
    at the end of the fourth undesignated paragraph the following: ``If 
    the offense involves a pre-retail medical product (as defined in 
    section 670) the punishment for the offense shall be the same as 
    the punishment for an offense under section 670 unless the 
    punishment under this section is greater.''.
    (e) Priority Given to Certain Investigations and Prosecutions.--The 
Attorney General shall give increased priority to efforts to 
investigate and prosecute offenses under section 670 of title 18, 
United States Code, that involve pre-retail medical products.
SEC. 5. AMENDMENT TO EXTEND WIRETAPPING AUTHORITY TO NEW OFFENSE.
    Section 2516(1) of title 18, United States Code, is amended--
        (1) by redesignating paragraph (s) as paragraph (t);
        (2) by striking ``or'' at the end of paragraph (r); and
        (3) by inserting after paragraph (r) the following:
        ``(s) any violation of section 670 (relating to theft of 
    medical products); or''.
SEC. 6. REQUIRED RESTITUTION.
    Section 3663A(c)(1)(A) of title 18, United States Code, is 
amended--
        (1) in clause (ii), by striking ``or'' at the end;
        (2) in clause (iii), by striking ``and'' at the end and 
    inserting ``or''; and
        (3) by adding at the end the following:
            ``(iv) an offense under section 670 (relating to theft of 
        medical products); and''.
SEC. 7. DIRECTIVE TO UNITED STATES SENTENCING COMMISSION.
    (a) In General.--Pursuant to its authority under section 994 of 
title 28, United States Code, and in accordance with this section, the 
United States Sentencing Commission shall review and, if appropriate, 
amend the Federal sentencing guidelines and policy statements 
applicable to persons convicted of offenses under section 670 of title 
18, United States Code, as added by this Act, section 2118 of title 18, 
United States Code, or any another section of title 18, United States 
Code, amended by this Act, to reflect the intent of Congress that 
penalties for such offenses be sufficient to deter and punish such 
offenses, and appropriately account for the actual harm to the public 
from these offenses.
    (b) Requirements.--In carrying out this section, the United States 
Sentencing Commission shall--
        (1) consider the extent to which the Federal sentencing 
    guidelines and policy statements appropriately reflect--
            (A) the serious nature of such offenses;
            (B) the incidence of such offenses; and
            (C) the need for an effective deterrent and appropriate 
        punishment to prevent such offenses;
        (2) consider establishing a minimum offense level under the 
    Federal sentencing guidelines and policy statements for offenses 
    covered by this Act;
        (3) account for any additional aggravating or mitigating 
    circumstances that might justify exceptions to the generally 
    applicable sentencing ranges;
        (4) ensure reasonable consistency with other relevant 
    directives, Federal sentencing guidelines and policy statements;
        (5) make any necessary conforming changes to the Federal 
    sentencing guidelines and policy statements; and
        (6) ensure that the Federal sentencing guidelines and policy 
    statements adequately meet the purposes of sentencing set forth in 
    section 3553(a)(2) of title 18, United States Code.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.

Summary: Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012 or the SAFE DOSES Act - Amends the federal criminal code to prohibit, in or using any means or facility of interstate or foreign commerce: (1) embezzling, stealing, obtaining by fraud or deception, or knowingly and unlawfully taking, carrying away, or concealing a medical product that has not yet been made available for retail purchase by a consumer (pre-retail medical product); (2) knowingly and falsely making, altering, forging, or counterfeiting the labeling or documentation of such a product; (3) knowingly possessing, transporting, or trafficking in a product involved in such a violation; (4) buying or otherwise obtaining, or selling or distributing, with intent to defraud, such a product that has expired or been stolen; or (5) attempting or conspiring to commit such a violation.

Makes such a violation an aggravated offense if: (1) the defendant is employed by, or is an agent of, an organization in the supply chain for the product; or (2) the violation involves the use of violence, force, a threat of violence or force, or the use of a deadly weapon, results in serious bodily injury or death, or is subsequent to a prior conviction for an offense under this Act.

Prescribes criminal and civil penalties for violations, including a civil penalty of up to the greater of 3 times the economic loss attributable to the violation or $1 million.

Provides for civil forfeiture for any property which constitutes or is derived from proceeds traceable to such a violation.

Requires the penalties under this Act to apply for the following offenses involving a pre-retail medical product: (1) interstate and foreign travel or transportation in aid of racketeering enterprises; (2) engaging in monetary transactions in property derived from specified unlawful activity; (3) breaking into or entering carrier facilities with intent to commit larceny; and (4) the transportation, sale, or receipt of stolen property. Directs the Attorney General to give increased priority to efforts to investigate and prosecute offenses involving pre-retail medical products.

Extends provisions authorizing wiretapping and requiring victim restitution to offenses relating to theft of a pre-retail medical product.

Directs the U.S. Sentencing Commission to review and, if appropriate, amend the sentencing guidelines and policy statements applicable to offenses related to pre-retail medical product theft or robberies and burglaries involving controlled substances to reflect congressional intent that penalties are sufficient to deter and punish such offenses and to appropriately account for actual harm to the public.